Revenues of Omega Therapeutics, Inc. from 30 Sep 2022 to 30 Sep 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Omega Therapeutics, Inc. quarterly and annual Revenues in USD history and change rate from 30 Sep 2022 to 30 Sep 2024.
  • Omega Therapeutics, Inc. Revenues for the quarter ending 30 Sep 2024 was $2,612,000, a 214% increase year-over-year.
  • Omega Therapeutics, Inc. Revenues for the twelve months ending 30 Sep 2024 was $8,094,000.
  • Omega Therapeutics, Inc. annual Revenues for 2023 was $3,094,000, a 49% increase from 2022.
Source SEC data
View on sec.gov
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Change (%)
Revenues, Annual (USD)
Revenues, YoY Annual Change (%)

Omega Therapeutics, Inc. Quarterly Revenues (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $8,094,000 $2,612,000 +$1,781,000 +214% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $6,313,000 $2,134,000 +$1,375,000 +181% 01 Apr 2024 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $4,938,000 $2,360,000 +$1,844,000 +357% 01 Jan 2024 31 Mar 2024 10-Q 06 May 2024 2024 Q1
Q4 2023 $3,094,000 $988,000 01 Oct 2023 31 Dec 2023 10-K 28 Mar 2024 2023 FY
Q3 2023 $831,000 +$236,000 +40% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2024 Q3
Q2 2023 $759,000 01 Apr 2023 30 Jun 2023 10-Q 06 Aug 2024 2024 Q2
Q1 2023 $516,000 01 Jan 2023 31 Mar 2023 10-Q 06 May 2024 2024 Q1
Q3 2022 $595,000 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3

Omega Therapeutics, Inc. Annual Revenues (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $3,094,000 +$1,021,000 +49% 01 Jan 2023 31 Dec 2023 10-K 28 Mar 2024 2023 FY
2022 $2,073,000 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.